Cargando…
Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man
CONTEXT: 5α-Reductase 1 and 2 (SRD5A1, SRD5A2) inactivate cortisol to 5α-dihydrocortisol in addition to their role in the generation of DHT. Dutasteride (dual SRD5A1 and SRD5A2 inhibitor) and finasteride (selective SRD5A2 inhibitor) are commonly prescribed, but their potential metabolic effects have...
Autores principales: | Hazlehurst, Jonathan M., Oprescu, Andrei I., Nikolaou, Nikolaos, Di Guida, Riccardo, Grinbergs, Annabel E. K., Davies, Nigel P., Flintham, Robert B., Armstrong, Matthew J., Taylor, Angela E., Hughes, Beverly A., Yu, Jinglei, Hodson, Leanne, Dunn, Warwick B., Tomlinson, Jeremy W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701851/ https://www.ncbi.nlm.nih.gov/pubmed/26574953 http://dx.doi.org/10.1210/jc.2015-2928 |
Ejemplares similares
-
Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
por: Lim, Teegan R., et al.
Publicado: (2019) -
Optimizing human hepatocyte models for metabolic phenotype and function: effects of treatment with dimethyl sulfoxide (DMSO)
por: Nikolaou, Nikolaos, et al.
Publicado: (2016) -
Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice
por: Dowman, Joanna K., et al.
Publicado: (2013) -
Theatres of Accumulation
por: Armstrong, Warwick
Publicado: (2013) -
5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
por: Nasiri, Maryam, et al.
Publicado: (2015)